journal article·2025-01Open access

High hydrostatic pressure treatment for advanced tissue grafts in reconstructive head and neck surgery

Friederike Kalle, Valentin Paul Stadler, Julia Kristin Brach, Vivica Freiin Grote, Christopher Pohl, Karoline Schulz, Michael Seidenstuecker, Anika Jonitz‐Heincke, Rainer Bader, Robert Mlynski, Daniel Strüder

Abstract

Abstract The increasing importance of regenerative medicine has resulted in a growing need for advanced tissue replacement materials in head and neck surgery. Allo‐ and xenogenic graft processing is often time‐consuming and can deteriorate the extracellular matrix (ECM). High hydrostatic pressure (HHP)‐treatment could allow specific devitalization while retaining the essential properties of the ECM. Porcine connective tissue and cartilage were HHP‐treated at 100–400 MPa for 10 min. Structural modifications following HHP‐exposure were examined using electron microscopy, while devitalization was assessed through metabolism and cell death analyses. Furthermore, ECM alterations and decellularization were evaluated by histology, biomechanical testing, and DNA content analysis. Additionally, the inflammatory potential of HHP‐treated tissue was evaluated in vivo using a dorsal skinfold chamber in a mouse model. The devitalization effects of HHP were dose‐dependent, with a threshold identified at 200 MPa for fibroblasts and chondrocytes. At this pressure level, HHP induced structural alterations in cells, with a shift toward late‐stage apoptosis. HHP‐treatment preserved ECM structure and biomechanical properties, but did not remove cell debris from the tissue. This study observed a pressure‐dependent increase of markers suggesting the occurrence of immunogenic cell death. In vivo investigations revealed an absence of inflammatory responses to HHP‐treated tissue, indicating a favorable biological response to HHP. In conclusion, application of HHP devitalizes fibroblasts and chondrocytes at 200 MPa while retaining the essential properties of the ECM. Prospectively, HHP may simplify the preparation of allo‐ and xenogenic tissue replacement materials and increase the availability of grafts in head and neck surgery.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Tissue Engineering and Regenerative Medicine · Electrospun Nanofibers in Biomedical Applications · Bone Tissue Engineering Materials

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Otorhinolaryngology, Head and Neck Surgery “Otto Körner” Rostock University Medical Center Rostock Germany

Department of Otorhinolaryngology – Head and Neck Surgery RWTH Aachen University Hospital Aachen Germany

Research Laboratory for Biomechanics and Implant Technology, Department of Orthopedics Rostock University Medical Center Rostock Germany

Department of General Surgery, Visceral, Thoracic and Vascular Surgery University Medical Center Greifswald Greifswald Germany

Medical Biology and Electron Microscopy Center Rostock University Medical Center Rostock Germany

G.E.R.N. Center for Tissue Replacement, Regeneration & Neogenesis, Department of Orthopedics and Trauma Surgery, Medical Center‐Albert‐Ludwigs‐University of Freiburg, Faculty of Medicine Albert‐Ludwigs‐University of Freiburg Freiburg Germany

Funding

European Social Fund Plus · Deutsche Forschungsgemeinschaft

References (81)

Show source-provided references
1. 10.1097/SCS.0b013e31822f3b1f10.1097/SCS.0b013e31822f3b1f ↗
2. 10.1016/J.ENG.2017.01.01010.1016/J.ENG.2017.01.010 ↗
3. 10.1001/archfaci.10.3.18710.1001/archfaci.10.3.187 ↗
4. 10.1007/s00106‐022‐01230‐510.1007/s00106‐022‐01230‐5 ↗
5. 10.3390/curroncol3012075310.3390/curroncol30120753 ↗
6. 10.1007/s00106‐005‐1372‐510.1007/s00106‐005‐1372‐5 ↗
7. 10.1080/0167683070137612210.1080/01676830701376122 ↗
8. Directive 2004/23/EC on setting standards of quality and safety for the donation, procurement, testing, processing, preservation, storage and distribution of human tissues and cells
9. 10.1016/j.tibtech.2012.12.00410.1016/j.tibtech.2012.12.004 ↗
10. 10.1007/s10856‐009‐3726‐010.1007/s10856‐009‐3726‐0 ↗
11. 10.1007/s11999‐017‐5330‐910.1007/s11999‐017‐5330‐9 ↗
12. 10.1016/j.arth.2014.03.02810.1016/j.arth.2014.03.028 ↗
13. 10.7507/1002‐1892.20190307810.7507/1002‐1892.201903078 ↗
14. 10.1007/s10561‐013‐9396‐710.1007/s10561‐013‐9396‐7 ↗
15. 10.1007/s10439‐014‐1161‐y10.1007/s10439‐014‐1161‐y ↗
16. 10.1016/j.cpm.2014.09.01110.1016/j.cpm.2014.09.011 ↗
17. 10.1016/j.actbio.2015.05.02510.1016/j.actbio.2015.05.025 ↗
18. 10.3389/fbioe.2023.126440910.3389/fbioe.2023.1264409 ↗
19. 10.1067/j.cpradiol.2021.09.00810.1067/j.cpradiol.2021.09.008 ↗
20. 10.1016/j.cpm.2018.02.00310.1016/j.cpm.2018.02.003 ↗
21. 10.1371/journal.pone.025416010.1371/journal.pone.0254160 ↗
22. 10.1007/s00167‐013‐2493‐010.1007/s00167‐013‐2493‐0 ↗
23. 10.3390/jcm811177110.3390/jcm8111771 ↗
24. 10.1080/2002409105427410.1080/20024091054274 ↗
25. 10.1016/j.lwt.2010.11.00110.1016/j.lwt.2010.11.001 ↗
26. 10.1080/09168451.2017.128172310.1080/09168451.2017.1281723 ↗
27. 10.1016/j.biotechadv.2010.04.00110.1016/j.biotechadv.2010.04.001 ↗
28. 10.3389/fbioe.2021.73026610.3389/fbioe.2021.730266 ↗
29. 10.1007/s10561-017-9678-610.1007/s10561-017-9678-6 ↗
30. 10.2174/09298670878590916610.2174/092986708785909166 ↗
31. 10.3390/ijms2111383610.3390/ijms21113836 ↗
32. 10.1111/j.1749‐6632.2010.05743.x10.1111/j.1749‐6632.2010.05743.x ↗
33. 10.3389/fonc.2019.0080510.3389/fonc.2019.00805 ↗
34. 10.1016/j.mvr.2013.07.00610.1016/j.mvr.2013.07.006 ↗
35. 10.1097/BCR.0b013e3182a226df10.1097/BCR.0b013e3182a226df ↗
36. 10.1016/j.actbio.2014.07.00410.1016/j.actbio.2014.07.004 ↗
37. 10.1016/j.actbio.2013.02.01310.1016/j.actbio.2013.02.013 ↗
38. 10.1002/jbm.b.3352810.1002/jbm.b.33528 ↗
39. 10.1002/jbm.a.3482610.1002/jbm.a.34826 ↗
40. 10.22203/eCM.v022a1210.22203/eCM.v022a12 ↗
41. 10.1080/09537104.2016.123569310.1080/09537104.2016.1235693 ↗
42. 10.1038/s41598‐022‐13924‐510.1038/s41598‐022‐13924‐5 ↗
43. 10.3791/5517410.3791/55174 ↗
44. 10.1038/s41598‐017‐17204‐510.1038/s41598‐017‐17204‐5 ↗
45. 10.1097/MD.000000000001881010.1097/MD.0000000000018810 ↗
46. 10.1007/s12070‐023‐03517‐710.1007/s12070‐023‐03517‐7 ↗
47. 10.1007/BF0354643410.1007/BF03546434 ↗
48. 10.1016/j.ijporl.2020.11042710.1016/j.ijporl.2020.110427 ↗
49. 10.1007/s10561‐022‐10015‐710.1007/s10561‐022‐10015‐7 ↗
50. 10.1088/1748‐605X/acb02e10.1088/1748‐605X/acb02e ↗
51. 10.3205/iprs00011210.3205/iprs000112 ↗
52. 10.1038/s41419‐020‐03221‐210.1038/s41419‐020‐03221‐2 ↗
53. 10.1093/asjof/ojac08510.1093/asjof/ojac085 ↗
54. 10.1097/PRS.000000000000920310.1097/PRS.0000000000009203 ↗
55. 10.1002/jbm.a.3317110.1002/jbm.a.33171 ↗
56. 10.1016/j.biomaterials.2008.01.03710.1016/j.biomaterials.2008.01.037 ↗
57. 10.1007/s00167‐006‐0036‐710.1007/s00167‐006‐0036‐7 ↗
58. 10.3390/ma1405106910.3390/ma14051069 ↗
59. High hydrostatic pressure‐induced cell death in human chondrocytes and chondrosarcoma cells
60. 10.3892/or.10.6.185110.3892/or.10.6.1851 ↗
61. 10.3390/mi1212148610.3390/mi12121486 ↗
62. 10.1038/s41420‐023‐01671‐z10.1038/s41420‐023‐01671‐z ↗
63. 10.3168/jds.2009‐278610.3168/jds.2009‐2786 ↗
64. Chapter A06
65. 10.1002/jor.2435010.1002/jor.24350 ↗
66. 10.1088/1748‐605X/aa6c6d10.1088/1748‐605X/aa6c6d ↗
67. 10.1177/088532821665609910.1177/0885328216656099 ↗
68. 10.1038/srep3374710.1038/srep33747 ↗
69. Effect of high hydrostatic pressure on biological properties of extracellular bone matrix proteins
70. 10.1002/adhm.20140016510.1002/adhm.201400165 ↗
71. 10.1080/0192623070132033710.1080/01926230701320337 ↗
72. 10.1038/nri221510.1038/nri2215 ↗
73. 10.1186/s40779‐015‐0039‐010.1186/s40779‐015‐0039‐0 ↗
74. 10.1007/s00106‐023‐01374‐y10.1007/s00106‐023‐01374‐y ↗
75. 10.1007/s00441‐014‐1982‐x10.1007/s00441‐014‐1982‐x ↗
76. 10.1007/s12026‐015‐8720‐710.1007/s12026‐015‐8720‐7 ↗
77. 10.1016/j.biomaterials.2012.04.01710.1016/j.biomaterials.2012.04.017 ↗
78. 10.1016/j.biomaterials.2017.03.01610.1016/j.biomaterials.2017.03.016 ↗
79. 10.1007/s13770‐020‐00314‐z10.1007/s13770‐020‐00314‐z ↗
80. 10.1016/j.ebiom.2020.10319610.1016/j.ebiom.2020.103196 ↗
81. 10.1002/jbm.b.3538310.1002/jbm.b.35383 ↗